Etoricoxib Tablets 60mg (Hainitan) – Low price wholesale comparison

Etoricoxib Tablets 60mg (Hainitan) – Low price wholesale comparison

$1.00

Etoricoxib Tablets (Hainitan / ???) contain 60?mg of etoricoxib per tablet. Manufactured by Shandong Langnuo Pharmaceutical Co., Ltd. under NMPA approval H20213565, these tablets are used in laboratory research related to pain, inflammation, and arthritis modeling.?? For laboratory research use only. Not for human or veterinary use.?Please consult staff for other specifications and uses?

EMI starting from $0.00/month - View Plans

Description

Etoricoxib is a selective cyclooxygenase-2 (COX-2) inhibitor, classified under nonsteroidal anti-inflammatory drugs (NSAIDs). It is used in preclinical and pharmacodynamic research to model inflammation, osteoarthritis, rheumatoid arthritis, and acute pain. Etoricoxib exhibits a targeted action by sparing COX-1 and selectively inhibiting COX-2, making it ideal for comparative studies with other NSAIDs.

This 60?mg strength is suitable for dose-response assays and chronic administration research.


Etoricoxib Tablets Product Specifications

ParameterDetails
Product NameEtoricoxib Tablets (Hainitan / ???)
Active IngredientEtoricoxib
CAS Number202409-33-4
Molecular FormulaC??H??ClN?O?S
Molecular Weight358.84 g/mol
Strength60?mg per tablet
FormulationOral tablet
Dosage FormFilm-coated tablet
Quantity per Box6 tablets
Approval Number????H20213565
Product Code86910323000086
ManufacturerShandong Langnuo Pharmaceutical Co., Ltd.
Barcode6907031122494
Storage ConditionsStore below 25?°C, protect from moisture and light
Intended UseLaboratory research only

Etoricoxib Tablets Mechanism of Action

Etoricoxib selectively inhibits COX-2 enzymes, which are responsible for the synthesis of prostaglandins involved in inflammation, swelling, and pain. It does not significantly affect COX-1, preserving gastrointestinal protection and platelet function. This mechanism is suitable for studying:

  • Anti-inflammatory mechanisms

  • Pain signaling pathways

  • NSAID-induced side effects

  • Arthritis progression in animal models


Etoricoxib Tablets Research Applications

  • Rheumatoid arthritis and osteoarthritis models

  • Acute and chronic inflammation studies

  • Pain modulation and analgesic testing

  • Comparative research with non-selective NSAIDs

  • COX-2 inhibitor pharmacokinetics


Etoricoxib Tablets Side Effects (Observed in Lab Settings)

  • Gastrointestinal discomfort (low incidence vs traditional NSAIDs)

  • Elevated liver enzymes in long-term studies

  • Cardiovascular effects at high doses

  • Renal function fluctuations

  • Headache or dizziness in animal subjects


Safety & Handling

  • Use appropriate lab PPE (gloves, goggles, lab coat)

  • Avoid inhalation and contact with eyes or skin

  • Handle in a well-ventilated lab setting

  • Not for use in humans or animals

  • Dispose of according to institutional safety regulations


Core Keywords

Etoricoxib tablets, CAS 202409-33-4, COX-2 inhibitor, Hainitan etoricoxib, NSAID for lab research, anti-inflammatory model drug, etoricoxib 60mg research, osteoarthritis inflammation research, lab-grade etoricoxib, etoricoxib for pain models


Research Use Disclaimer

This product is intended strictly for laboratory research. It is not approved for therapeutic, diagnostic, or veterinary use. Handle only in certified facilities by trained research professionals.

Additional information

Weight1 kg
Dimensions26 × 23 × 26 cm

Reviews

There are no reviews yet.

Be the first to review “Etoricoxib Tablets 60mg (Hainitan) – Low price wholesale comparison”

Your email address will not be published. Required fields are marked *

Q1: What is Etoricoxib’s CAS number?

A1: The CAS number for Etoricoxib is 202409-33-4.

Q2: Is this product approved for clinical use?

A2: No. This product is strictly for laboratory research purposes only.

Q3: Do you offer bulk or international orders?

A3: Yes. We support wholesale, OEM, and global shipping for qualified labs.

Q4: Can I get COA and SDS documents?

A4: Yes, Certificate of Analysis and Safety Data Sheet are available upon request.

Q5: How does Etoricoxib differ from other NSAIDs?

A5: It selectively inhibits COX-2 while sparing COX-1, reducing GI side effects and making it suitable for long-term inflammatory studies.


EMI Options